Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Penumbra Inc

0P8
Current price
167 EUR +0.15 EUR (+0.09%)
Last closed 186.94 USD
ISIN US70975L1070
Sector Healthcare
Industry Medical Devices
Exchange Stuttgart Exchange
Capitalization 7 261 478 912 USD
Yield for 12 month -28.45 %
1Y
3Y
5Y
10Y
15Y
0P8
21.11.2021 - 28.11.2021

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California. Address: One Penumbra Place, Alameda, CA, United States, 94502

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

202.47 USD

P/E ratio

519.2778

Dividend Yield

Current Year

+1 058 522 000 USD

Last Year

+847 133 000 USD

Current Quarter

+299 403 000 USD

Last Quarter

+278 655 000 USD

Current Year

+682 643 000 USD

Last Year

+535 207 000 USD

Current Quarter

+160 343 000 USD

Last Quarter

+178 652 000 USD

Key Figures 0P8

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 105 592 000 USD
Operating Margin TTM -1.34 %
PE Ratio 519.2778
Return On Assets TTM 3.32 %
PEG Ratio -62.27
Return On Equity TTM 1.28 %
Wall Street Target Price 202.47 USD
Revenue TTM 1 133 682 944 USD
Book Value 29.9 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 14.5 %
Dividend Yield
Gross Profit TTM 535 207 000 USD
Earnings per share 0.36 USD
Diluted Eps TTM 0.36 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 27.3 %
Profit Margin 1.26 %

Dividend Analytics 0P8

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 0P8

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 10:1
Payout Ratio
Last Split Date 16.11.2014
Dividend Date

Stock Valuation 0P8

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 519.2778
Forward PE 52.6316
Enterprise Value Revenue 6.3074
Price Sales TTM 6.4052
Enterprise Value EBITDA 376.8039
Price Book MRQ 6.2533

Financials 0P8

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 0P8

For 52 weeks

148 USD 277.34 USD
50 Day MA 188.92 USD
Shares Short Prior Month 2 288 134
200 Day MA 215.68 USD
Short Ratio 4.09
Shares Short 2 419 195
Short Percent 8.77 %